Flare Capital Partners provides capital for early-stage and emerging healthcare technology companies. The firm invests across the United States, recognizing that healthcare technology innovation is occurring in many cities around the country.

Flare Capital Partners

Define Ventures is an early-stage venture capital firm solely focused on investing in digital health companies. They partner with entrepreneurs with the digital health focus and expertise that they deserve to redefine healthcare.

Define Ventures

Humana creates innovative solutions and resources that help people with their healthcare needs. The company is an innovator with a commitment to service, health, and wellness. Their focus on people, choice, engagement and innovation guides our business practices and decision-making. In addition to group health plans, Humana's diverse lines of business work to serve all types of consumers. Humana was founded in 1964 and is based in Louisville, Kentucky, United States.

Humana

Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics, and genomics.

Polaris Partners

Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance the quality of life, and/or reduce system costs. They invest in both privately held and publicly traded life science companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multiple market cycles. Their venture growth strategy is rooted in building a balanced portfolio of clinical-stage and commercial-stage companies with clinically de-risked assets, favorable valuations relative to risk profile, and attractive expected returns within three to five years from the initial investment. Longitude Capital seeks to identify new investment opportunities by tapping into their broad network of industry relationships or through the execution of intensive thematic research into emerging therapeutic areas or industry sub-sectors. They utilize a variety of investment structures, including traditional venture capital, asset spin-outs, recapitalizations, PIPEs, open market purchases, royalties, and other equity and equity-linked instruments.

Longitude Capital

Deerfield is an investment management firm. They provide a healthcare ecosystem through information and investment. They also provide private and public investments across the life science, medical device, diagnostic, digital health, and health service industries.

Deerfield

Deerfield Management is a healthcare company that works across investment, information, and philanthropy. The company was founded in 1994 and is based in New York.

Deerfield Management

Cohere Health

Cohere Health is a healthcare technology company, focused on improving the efficiency and effectiveness of healthcare delivery. Cohere Health aims to simplify the complexities of the healthcare system by leveraging technology to streamline processes, enhance communication, and ultimately improve patient outcomes. The company may provide solutions to various stakeholders in the healthcare ecosystem, including patients, providers, and payers.

<div>Cohere Health provides a platform for improving the prior authorization and clinical review processes in healthcare. Its platform uses artificial intelligence (AI) to automate and streamline clinical review and prior authorization processes by applying evidence-based guidelines, integrating with electronic medical records (EMR), and facilitating communication between health plans and providers. Cohere Health offers two delivery options for its platform: Cohere PaaS and Cohere Complete. Cohere PaaS allows health plans to license the platform as a service (PaaS) and use it with their own internal staff. Cohere Complete includes the platform plus intake and clinical staff to provide fully outsourced and delegated specialty services.</div>

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

Cohere Health on LinkedIn: Cohere Health, Medical Mutual, and Rhyme, today announced a strategic…

<div>
 
 Cohere Health provides a platform for improving the prior authorization and clinical review processes in healthcare. Its platform uses artificial intelligence (AI) to automate and streamline clinical review and prior authorization processes by applying evidence-based guidelines, integrating with electronic medical records (EMR), and facilitating communication between health plans and providers. Cohere Health offers two delivery options for its platform: Cohere PaaS and Cohere Complete. Cohere PaaS allows health plans to license the platform as a service (PaaS) and use it with their own internal staff. Cohere Complete includes the platform plus intake and clinical staff to provide fully outsourced and delegated specialty services.
 
 
 The company partners with healthcare plans and physicians, offering its platform on a subscription basis.
 
 
 Cohere Health notes that as of January 2024, it is able to immediately approve 83% of authorization requests. On requests requiring clinician review, turnaround time averages 4.5 days and just nine hours for urgent cases.&nbsp;
 
 
 
 
 Funding and financials
 
 
 In February 2024, the company raised USD 
 50 million in a funding round led by Deerfield Management, along with contributions from other investors. The raised capital was set aside to aid the company&rsquo;s expansion efforts. 
 
 
 
</div>

<div>
 
 Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
 
 
 In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
 
 
 
</div>

Nice Healthcare

Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications.Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.

Amicomed

Winston is a men’s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients.The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.

Winston

<div>
 
 Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
 
 
 The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care, wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
 
 
 Key Customers and partnerships
 
 
 Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
 
 
 Fundings and financials
 
 
 As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
 
 
 In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
 an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
 
 Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
 <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
 acquired by financial services company Sun Life Financial
 </a>
 for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
 
 
 
</div>

Dialogue

Grin offers telemedicine and remote monitoring services for orthodontic needs such as braces and teeth straightening. Patients can conduct self-scans (using a Grin device made available to patients in collaboration with 3M) which can be connected to their smartphones and share the feed with orthodontists to access dental solutions. The company plans to go to a subscription-based model after the pandemic. The app also encourages patients to have a 40-second check monthly and share the scan with a dentist in order to allow patients to regularly maintain their dental hygiene.Grin is the only Telehealth disruptor covered on the hub that provides virtual orthopaedic consultations.Funding and financialsIn April 2021, the New York-based teledental platform concluded a seed funding of USD 14 million, and the funds will be allocated to develop additional functionalities by building out its technology. The proceeds will also be used to scale up its team, expand its geographic footprint, and add doctors to the company’s orthodontic partner network.

Grin

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates. 


A platform that facilitates the transmission of patient data to different locations for further evaluation and interpretation by medical specialists. 


A digital platform that offers specialty care services to address the specific needs of a patient or demographic, including consultations where patients are generally reluctant to meet practitioners face-to-face.

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

Companies developing B2B software solutions for patient engagement, care navigation, practice management, and electronic health records integration to facilitate telehealth services for healthcare providers. 

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

<div>
 
 Cohere Health, a healthcare startup working towards simplifying the prior authorization process, has raised USD 50 million in a funding round. Deerfield Management led the round with contributions from other investors, bringing the total funding to USD 106 million.
 The company plans to use the newly raised funds to support its expansion efforts.
 According to Cohere Health, they can instantly approve 83% of authorization requests as of January 2024. For the requests needing clinician review, the average turnaround time is 4.5 days, while for urgent cases it drops down to nine hours.
 
</div>

Cohere Health

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless